Thin on the left - 1 of 7 outlets

7 outlets · Left 1 · Center 3 · Right 3
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
each line: one outlet's first article — above the track left · below right · across center
First reported by CNBC (Center); 7 outlets over 26h. The left followed 9h later.
CNBC · +7h NewsNation · +17h Reuters · +17h Fox News · +22h The Epoch Times · +22h New York Post · +26h ABC News
Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of Ozempic’s highest dose, according to new clinical trial results shared Wednesday. ABC News medical correspondent Dr. Darien Sutton shares the latest.
Watch at youtube.com →Lilly's next-gen drug outshines Ozempic on weight loss, blood sugar control in trial Reuters
Read at reuters.com →Eli Lilly’s experimental weight-loss drug retatrutide reduced sleep apnea symptoms by over 50% in 68% of trial participants.
Read at nypost.com →Judge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo Nordisk The Epoch Times
Read at theepochtimes.com →Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
8 articles (1 video), newest first · filter by side
Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.